Xifaxan 550 MG Oral Tablet
- RxCUI
- 856666
- RxNorm name
- Xifaxan 550 MG Oral Tablet
- Display name
- Xifaxan 550 MG Oral Tablet
- Full name
- Xifaxan 550 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XIFAXAN | RIFAXIMIN | Cardinal Health 107, LLC | 7afafa63-3236-4212-9589-045db6b01c0b | 2025-08-27 | Warnings, Adverse reactions | 856666 |
| XIFAXAN | RIFAXIMIN | Salix Pharmaceuticals, Inc. | c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | 2025-06-25 | Warnings, Adverse reactions | 856666 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | Xifaxan 550 MG Oral Tablet | SY | 50 | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN ® (rifaximin) tablets, for oral use Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250625 |
| c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | rifaximin 550 MG Oral Tablet [XIFAXAN] | SBD | 50 | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN ® (rifaximin) tablets, for oral use Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250625 |
| c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | XIFAXAN 550 MG Oral Tablet | PSN | 50 | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN ® (rifaximin) tablets, for oral use Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250625 |
| 7afafa63-3236-4212-9589-045db6b01c0b | rifaximin 550 MG Oral Tablet [XIFAXAN] | SBD | 14 | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN ® (rifaximin) tablets, for oral use Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250827 |
| 7afafa63-3236-4212-9589-045db6b01c0b | XIFAXAN 550 MG Oral Tablet | PSN | 14 | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN ® (rifaximin) tablets, for oral use Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250827 |
| 7afafa63-3236-4212-9589-045db6b01c0b | Xifaxan 550 MG Oral Tablet | SY | 14 | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN ® (rifaximin) tablets, for oral use Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250827 |
| 523f0320-cc73-445a-a48d-7a181c182307 | rifaximin 550 MG Oral Tablet [XIFAXAN] | SBD | 2 | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN® (rifaximin) Tablets Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20111228 |
| 523f0320-cc73-445a-a48d-7a181c182307 | Xifaxan 550 MG Oral Tablet | SY | 2 | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN® (rifaximin) Tablets Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20111228 |
| 523f0320-cc73-445a-a48d-7a181c182307 | XIFAXAN 550 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN® (rifaximin) Tablets Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20111228 |